FR-193879

• CAT Number: I006878
• CAS Number: 194928-82-0
• Molecular Formula: C20H18N4O5S3
• Molecular Weight: 490.57
• Purity: ≥95%
• Synonyms: FR-193879; FR193879; FR 193879.;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((4-(2-amino-2-oxoethyl)-2-thiazolyl)thio)-8-oxo-7-((2-phenylacetyl)amino)-, (6R,7R)-
• Solubility: Soluble in DMSO
• Storage: 0 - 4°C for short term or -20 °C for long term
• IUPAC Name: (6R,7R)-3-[[4-(2-amino-2-oxoethyl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-7-[(2-phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• InChI: InChI=1S/C20H18N4O5S3/c21-13(25)7-11-8-31-20(22-11)32-12-9-30-18-15(17(27)24(18)16(12)19(28)29)23-14(26)6-10-4-2-1-3-5-10/h1-5,8,15,18H,6-7,9H2,(H2,21,25)(H,23,26)(H,28,29)/t15-,18-/m1/s1
• InChIKey: YINUFDSCPLNLPS-CRAIPNDOSA-N
• SMILES: C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)SC4=NC(=CS4)CC(=O)N

FR-193879（Cat No.:I006878）is an experimental small molecule inhibitor that targets the protein kinase p90 ribosomal S6 kinase (RSK), a key player in various signaling pathways, including those regulating cell growth, survival, and differentiation. By inhibiting RSK, FR-193879 aims to disrupt these processes, making it a promising candidate for cancer treatment, as RSK is often overactive in various cancers. It is also being explored for its potential in treating other diseases linked to aberrant cell signaling. Currently in preclinical studies, its safety, efficacy, and therapeutic potential are being evaluated.